Abstract:The enteric nervous system is the part of the autonomic nervous system that directly controls the gastrointestinal tract. Derived from a multipotent, migratory cell population called the neural crest, a complete enteric nervous system is necessary for proper gut function. Disorders that arise as a consequence of defective neural crest cell development are termed neurocristopathies. One such disorder is Hirschsprung disease (HSCR), also known as congenital megacolon or intestinal aganglionosis. HSCR occurs in 1/5000 live births and typically presents with the inability to pass meconium, along with abdominal distension and discomfort that usually requires surgical resection of the aganglionic bowel. This disorder is characterized by a congenital absence of neurons in a portion of the intestinal tract, usually the distal colon, because of a disruption of normal neural crest cell migration, proliferation, differentiation, survival, and/or apoptosis. The inheritance of HSCR disease is complex, often non-Mendelian, and characterized by variable penetrance. Extensive research has identified a number of key genes that regulate neural crest cell development in the pathogenesis of HSCR including RET, GDNF, GFRα1, NRTN, EDNRB, ET3, ZFHX1B, PHOX2b, SOX10, and SHH. However, mutations in these genes account for only ∼50% of the known cases of HSCR. Thus, other genetic mutations and combinations of genetic mutations and modifiers likely contribute to the etiology and pathogenesis of HSCR. The aims of this review are to summarize the HSCR phenotype, diagnosis, and treatment options; to discuss the major genetic causes and the mechanisms by which they disrupt normal enteric neural crest cell development; and to explore new pathways that may contribute to HSCR pathogenesis.

Opportunities for Novel Diagnostic and Cell-Based Therapies for Hirschsprung Disease.

New frontiers in the treatment of Hirschsprung disease

Hirschsprung-Associated Enterocolitis: Transformative Research from Bench to Bedside

Established and emerging concepts in Hirschsprung's-associated enterocolitis

The Pathologist's Role in the Diagnosis of Hirschsprung's Disease

Hirschsprung's disease associated enterocolitis: A comprehensive review

Minimally Invasive Surgery for Hirschsprung Disease: Current Practices and Future Directions

Human Pluripotent Stem Cell-Based Models for Hirschsprung Disease: From 2-D Cell to 3-D Organoid Model

Controversies in Hirschsprung surgery

Genetics of Hirschsprung's disease

Chinese expert consensus statement on the diagnosis and treatment of Hirschsprung disease

Schwann Cells in the Aganglionic Colon of Hirschsprung Disease Can Generate Neurons for Regenerative Therapy.

Hirschsprung's disease. Management

Therapeutic approaches in Hirschsprung's disease: clinical cases

Hirschsprung disease — integrating basic science and clinical medicine to improve outcomes

Analysis of enteric nervous system and intestinal epithelial barrier to predict complications in Hirschsprung's disease

Recent Developments in Pathogenesis of Hirschsprung's Disease

The developmental etiology and pathogenesis of Hirschsprung disease

Early diagnosis and surgical treatment of Hirschsprung’s disease in newborns

Hirschsprung's associated enterocolitis

Intestinal microenvironment abnormalities of Hirschsprung disease and its potential clinical transformation